DUBLIN--(BUSINESS WIRE)--The "Global Molecular Diagnostics for Infectious Disease 2019 to 2023 - Markets, Strategies and Trends, Volume & Price Forecasts by Pathogen and by Country" report has been added to ResearchAndMarkets.com's offering.
Improvements in speed and accuracy drive demand for molecular diagnostic tests for infectious disease. Genetics advances create need for new diagnostics creating a fast moving market driven by technical change.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing. In spite of the steady decline of disease prevalence, the diagnostic sector keeps growing. Find out why in the informative report.
Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.
- Changing demographics
- Emerging economies and global prosperity
- Biotechnology advances in genetics
- Pathogen evolution
- Climate change
- The rise of rapid testing
Exciting technical developments especially in the seesaw between sequencing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.
The report has hundreds of pages of information including a complete list of Current 2016 United States Medicare Fee Payment Schedules to help sharpen your pricing. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
The research makes you the expert in your organization. All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Market Analysis by Disease
3. Industry Overview
4. Market Trends
5. Molecular Dx - Infectious Disease Recent Developments
6. Country Market Sizes - North America
7. Country Markets - Europe
8. Country Markets - Asia Pacific
9. Country Markets - Latin America, Africa & The Middle East
10. Global Market Summary
I. United States Medicare System: January 2016 Clinical Laboratory Fees Schedule - National Limit and Midpoint
II. FDA Approved Human Genetic Tests
III. FDA Approved Microbial Tests
III. FDA Approved Pharmacogenomics Tests
- Abbott Diagnostics
- BD Diagnostics
- Beckman Coulter
- Bio-Rad Laboratories
- Eiken Chemical
- Janssen Diagnostics
- Locus Biosciences
- Meridian Bioscience
- Mesa Biotech Inc
- Molecular Dx
- 'Origami' diagnostics
- Roche Molecular Diagnostics
- Sekisui Diagnostics
- Thermo Fisher
- Vela Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/bw68pq/global_molecular?w=4